Serum level of interleukin-8 and interleukin-10 as predictors for response to interferon–ribavirin combined therapy

Conclusion: We can consider serum IL-8 and IL-10 pretreatment levels as good predictive noninvasive markers to predict SVR to peg-IFN and RBV therapy in CHC patients.
Source: Egyptian Liver Journal - Category: Gastroenterology Tags: Original articles Source Type: research